BALLARINI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 14.938
AS - Asia 8.653
EU - Europa 7.098
SA - Sud America 1.099
Continente sconosciuto - Info sul continente non disponibili 984
AF - Africa 192
OC - Oceania 51
Totale 33.015
Nazione #
US - Stati Uniti d'America 14.144
SG - Singapore 2.771
IT - Italia 2.238
CN - Cina 1.796
VN - Vietnam 1.748
DE - Germania 1.235
RU - Federazione Russa 863
HK - Hong Kong 836
BR - Brasile 826
CA - Canada 620
SE - Svezia 599
GB - Regno Unito 409
IE - Irlanda 402
FR - Francia 268
IN - India 250
UA - Ucraina 221
KR - Corea 215
BD - Bangladesh 210
FI - Finlandia 172
AT - Austria 136
ID - Indonesia 130
JP - Giappone 117
TR - Turchia 107
AR - Argentina 100
IQ - Iraq 86
NL - Olanda 86
DK - Danimarca 79
MX - Messico 74
PL - Polonia 73
CH - Svizzera 69
LT - Lituania 67
ES - Italia 64
ZA - Sudafrica 60
PK - Pakistan 55
AU - Australia 46
BE - Belgio 45
SA - Arabia Saudita 42
EC - Ecuador 41
CO - Colombia 39
PH - Filippine 36
VE - Venezuela 32
EG - Egitto 30
IR - Iran 30
UZ - Uzbekistan 29
MY - Malesia 25
JM - Giamaica 24
MA - Marocco 23
PY - Paraguay 22
CL - Cile 20
CR - Costa Rica 18
TW - Taiwan 18
AE - Emirati Arabi Uniti 16
HN - Honduras 16
KZ - Kazakistan 16
TN - Tunisia 16
IL - Israele 15
TH - Thailandia 15
RO - Romania 13
ET - Etiopia 12
JO - Giordania 12
BG - Bulgaria 11
EU - Europa 10
KE - Kenya 10
OM - Oman 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
HU - Ungheria 9
NP - Nepal 9
UY - Uruguay 9
AO - Angola 8
NG - Nigeria 8
KW - Kuwait 7
TT - Trinidad e Tobago 7
LB - Libano 6
PE - Perù 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
KG - Kirghizistan 5
NI - Nicaragua 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
BH - Bahrain 4
BO - Bolivia 4
RS - Serbia 4
SY - Repubblica araba siriana 4
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
MN - Mongolia 3
MT - Malta 3
PA - Panama 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CU - Cuba 2
Totale 31.993
Città #
Ann Arbor 1.947
Singapore 1.670
San Jose 1.412
Ashburn 1.400
Dallas 1.147
Milan 846
Frankfurt am Main 822
Hong Kong 792
Ho Chi Minh City 525
Hanoi 404
Toronto 403
Dublin 388
Chandler 380
Council Bluffs 350
Wilmington 339
Los Angeles 331
New York 327
Beijing 281
Dearborn 259
Woodbridge 248
Boardman 236
Santa Clara 222
Houston 213
Chicago 198
Jacksonville 195
Fairfield 192
Hefei 168
Seoul 158
Princeton 151
Columbus 150
Rome 145
The Dalles 136
Vienna 114
Buffalo 109
Shanghai 107
Seattle 105
Nanjing 100
São Paulo 99
Moscow 91
Lauterbourg 89
Jakarta 84
Munich 84
Guangzhou 81
Helsinki 75
Orem 74
Phoenix 72
Tokyo 57
Da Nang 56
Montreal 56
Haiphong 53
Denver 52
Atlanta 51
Dong Ket 51
London 51
Brooklyn 50
Zurich 49
Vilnius 48
Warsaw 48
Washington 42
Baghdad 38
Cambridge 38
Carate Brianza 38
Chennai 38
Rio de Janeiro 38
Saint Petersburg 38
Turku 37
Altamura 36
Hải Dương 34
Lawrence 34
Nuremberg 34
Shenyang 34
Florence 33
Johannesburg 31
Pune 31
Basingstoke 30
Biên Hòa 30
Lachine 30
Stockholm 30
Brussels 29
Ha Long 29
Jinan 28
Kent 28
Ninh Bình 28
Ottawa 28
Tashkent 28
Turin 28
Daejeon 27
Nanchang 27
Poplar 27
Sacramento 27
Changsha 26
Falls Church 26
Fremont 26
Andover 25
Can Tho 25
Mexico City 25
Quận Bình Thạnh 25
Figino 24
Manchester 24
Amsterdam 23
Totale 19.618
Nome #
CIPN and its mechanism of development 681
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 648
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 605
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 586
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 541
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 530
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 529
miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease 497
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 495
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 492
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 489
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 475
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 460
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 454
Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa 450
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 448
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 441
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 440
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 435
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 391
miR-192-5p and CXCL2/NOD2 inverse correlation in celiac disease 371
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 368
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 360
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 359
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 354
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 353
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 352
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 351
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 350
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 348
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 346
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 342
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 333
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 330
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 321
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 319
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 317
Multiple Sclerosis Drug Therapy: from the Classical Pharmaceutical down to Cellular and Molecular Approach 312
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 309
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 307
Histone deacetylases inhibitors: a new frontier for neuroprotection? 306
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 304
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 302
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 301
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 301
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 301
Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation 301
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED ALTERATIONS LEADING TO PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 298
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 295
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 295
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 293
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 292
Caratterizzazione di un modello di encefalomielite autoimmune sperimentale e ruolo neuroprotettivo del progesterone 292
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 292
Bioresponsive Hyaluronic Acid-Based Hydrogel Inhibits Matrix Metalloproteinase-2 in Glioblastoma Microenvironment 290
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 290
Therapeutic potential of Mesenchymal Stem Cells for the treatment of type-1 Diabetes. 288
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 287
MSCs effect on Dark Agouti rats affected by chronic EAE 286
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 285
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 284
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 282
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 282
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 269
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY 268
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 268
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 264
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 260
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 258
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 253
Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis 250
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 248
Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis 248
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 247
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 246
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation 245
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons 239
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 239
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 238
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 237
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 237
Nose-to-brain delivery of polymeric nanoparticles 235
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 233
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 229
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 226
ERK1 and ERK2 involvement in human Mesenchymal Stem Cells adipogenic differentiation 214
Refinement Of Dorsal Root Ganglia Neurons Morphometry 214
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 211
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 205
Unravelling axonal damage mechanisms in peripheral nerves: the role of sodium-calcium (NCX) exchanger 191
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 187
Changes in neuroactive steroids in experimental autoimmune encephalomyelitis 182
THYMOQUINONE AS A POSSIBLE NEUROPROTECTIVE AGENT AGAINST PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 181
Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve 181
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 178
Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection? 170
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 162
Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model 157
Interleukin-6 as a keystone cytokine in experimental rat models of chemotherapy-induced peripheral neurotoxicity 156
Molecular Characterization of Oxaliplatin-Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations 154
Totale 31.816
Categoria #
all - tutte 96.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022966 0 0 0 137 118 139 56 71 51 80 103 211
2022/20232.231 217 516 292 231 198 314 57 103 133 40 62 68
2023/20241.699 57 64 57 116 197 352 302 98 101 47 57 251
2024/20254.784 258 459 436 224 384 208 323 199 548 665 430 650
2025/202613.663 1.871 1.100 1.607 1.192 1.123 723 1.795 603 1.038 1.048 752 811
2026/20273.481 693 624 1.401 763 0 0 0 0 0 0 0 0
Totale 33.015